Aspirin, angiotensin converting enzyme inhibitors and cardiac failure;Aspirine, inhibiteur de l'enzyme de conversion de l'angiotensine et insuffisance cardiaque

Archives des Maladies du Coeur et des Vaisseaux

Volumn 93, Issue 2, 2000, Pages 167-171

  De Groote, P ^a   Aumegeat V ^a   Meurice, Th ^a   Millaire, A ^a   Lamblin, N ^a   Lablanche, J M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROHORMONE;

ATHEROSCLEROSIS; BLOOD PRESSURE; CLINICAL TRIAL; DRUG INHIBITION; EXERCISE; HEART FAILURE; HUMAN; LUNG PRESSURE; MORTALITY; REVIEW; VASCULAR RESISTANCE; VASODILATATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 0343986404     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure. J Am Coll Cardiol 1992; 20: 1549-55.
2. Spaulding C, Charbonnier B, Cohen-Solal A et al. Acute hemodynamic interaction of aspirin and ticlopidine with enalapril: results of a double-blind, randomized comparative trial. Circulation 1998; 98: 757-65.
3. Nakamura M, Funakoshi T, Arakawa N et al. Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure. J Am Coll Cardiol 1994; 24: 1321-7.
4. Katz S, Radin M, Graves T et al. Effect of aspirin and ifetroban on skeletal muscle blood flow in patients with congestive heart failure treated with enalapril. J Am Coll Cardiol 1999; 34: 170-6.
5. Baur LH, Schipperheyn JJ, van der Laarse A et al. Combining salicylate and enalapril in patients with coronary artery disease and heart failure. Br Heart J 1995; 73: 227-36.
6. Guazzi M, Marenzi G, Alimento M, Contini M, Agostoni P. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997; 95: 1930-6.
7. Guazzi M, Pontone G, Agostoni P. Aspirin worsens exercise performance and pulmonary gas exchange in patients with heart failure who are taking angiotensin-converting enzyme inhibitors. Am Heart J 1999; 138: 254-60
8. Riegger GA, Kahles HW, Elsner D, Kromer EP, Kochsiek K. Effects of acetylsalicylic acid on renal function in patients with chronic heart failure. Am J Med 1991 ; 90: 571-5.
9. Dietz R, Nagel F, Osterziel K. Angiotensin-converting enzyme inhibitors and renal function in heart failure. Am J Cardiol 1992; 70: 119C-125C.
10. van Wijngaarden J, Smit AJ, de Graeff PA et al. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1994; 23: 240-5.
11. Guazzi M, Campodonico J, Celeste F et al. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin couteraction. Clin Pharmacol Ther 1998; 63: 79-86.
12. Jeserich M, Pape L, Just H et al. Effect of long-term angiotensin-converting enzyme inhibition on vascular function in patients with chronic congestive heart failure. Am J Cardiol 1995; 76: 1079-82.
13. Cleland JG. Anticoagulant and antiplatelet therapy in heart failure. Curr Opin Cardiol 1997; 12: 276-87.
14. Al-Khadra AS, Salem DN, Rand WM et al. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. J Am Coll Cardiol 1998; 31: 419-25.
15. Nguyen KN, Aursnes I, Kjekshus J. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). Am J Cardiol 1997; 79: 115-9.
16. Oosterga M, Anthonio RL, de Kam PJ et al. Effects of aspirin on angiotensin-converting enzyme inhibition and left ventricular dilation one year after acute myocardial infarction. Am J Cardiol 1998; 81: 1178-81.
17. Leor J, Reicher-Reiss H, Goldbourt U et al. Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors. A cohort study of 11575 patients with coronary artery disease. J Am Coll Cardiol 1999; 33: 1920-5.
18. Aumégeat V, de Groote P, Meurice T et al. Aspirin and angiotensin converting enzyme inhibitors in 445 patients with moderate congestive heart failure. J Am Coll Cardiol 1999 ; 33 : 214A.
19. Nawarskas JJ, Spinler SA. Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme inhibitors in hypertension or congestive heart failure? Pharmacotherapy 1998; 18: 1041-52.
20. Guéret P, Dubourg O, Vahanian A et al. L'étude CAPITOL. Essai de titration progressive du captopril après infarctus du myocarde avec altération de la fonction ventriculaire gauche. Arch Mal Cœur 1999; 92: 395-403.
21. Hornig B, Arakawa N, Drexler H. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998; 98: 2842-8.